Minocycline has also indicated to reduce the cytokine levels (IL-1β, TNF-α, and IL-6), which promoted neuro-inflammation and decreased pain behavior in a CCI model of neuropathic pain[24]. The gene discussed is IL1B; the disease is neuropathic pain.